Neisseria meningitidis with decreased susceptibility to penicillin in Saskatchewan, Canada

J M Blondeau1, F E Ashton, M Isaacson

  • 1Department of Clinical Microbiology, St. Paul's Hospital, Saskatoon, Ottawa, Canada.

Insights

Moderately penicillin-resistant Neisseria meningitidis (meningococcus) is emerging in Saskatchewan, Canada. This outbreak highlights the need for ongoing surveillance of antibiotic resistance in this pathogen.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Neisseria meningitidis is a leading cause of bacterial meningitis and sepsis.
  • Penicillin resistance in Neisseria meningitidis is uncommon in North America.
  • Serogroup C strains are a significant cause of invasive meningococcal disease.

Purpose of the Study:

  • To investigate an outbreak of meningococcal disease in Saskatchewan, Canada.
  • To characterize the antimicrobial susceptibility and genetic relatedness of the causative Neisseria meningitidis isolates.

Main Methods:

  • Pulsed-field gel electrophoresis (PFGE) was used for genomic fingerprinting.
  • Minimum inhibitory concentrations (MICs) of penicillin were determined for clinical isolates.

Main Results:

  • An outbreak of serogroup C Neisseria meningitidis was identified in Saskatoon, Saskatchewan.
  • All isolates exhibiting decreased penicillin susceptibility (MICs 0.12–0.25 µg/mL) shared identical genomic fingerprints.
  • These findings suggest a prevalent strain of moderately penicillin-resistant Neisseria meningitidis in the region.

Conclusions:

  • Moderately penicillin-resistant Neisseria meningitidis is circulating in Saskatchewan, Canada.
  • The identical genomic fingerprints indicate a common source or clonal spread of the resistant strain.
  • Enhanced surveillance for antibiotic resistance in Neisseria meningitidis is warranted in this region.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...